Complex Regional Pain Syndrome (CRPS) is a debilitating chronic pain condition. It is characterised by a severe burning, stinging and stabbing pain that CRPS sufferers describe as “unbearable” and “terrifying”. They are unable to use their painful limb. As a result, their ability to work and participate in social activities is severely restricted.
Currently, there are no treatments for CRPS for which the efficacy is supported by high-quality evidence. Because of the intense nature of CRPS pain, people often seek radical, unproven treatments that are potentially harmful.
Access to appropriate care is even more challenging for people who live far from metropolitan areas. To combat this, the growth of telehealth services has seen the digital transformation of primary care, allowing the delivery of services and expertise to remote and rural areas.
Promising new treatments for CRPS are now being tested in an Australian government funded trial called MEMOIR.
MEMOIR is being conducted entirely via telehealth, allowing people with CRPS, who are living anywhere in Australia, the opportunity to access promising treatments from the comfort of their lounge rooms. MEMOIR will test these promising treatments in 160 people with CRPS over the next 3 years.
Professor James McAuley of Neuroscience Research Australia, the chief investigator on the trial says, “The findings from MEMOIR could revolutionise care for people with CRPS.”
The trial is actively recruiting.
To Find Out More
If you have CRPS and/or are interested in finding out more information about the trial, please visit: www.neura.edu.au/memoir
If you are a clinician and would like to refer your patient, please contact the MEMOIR team: email@example.com
Want to read the full Magazine? Download Rev'd Up Here